Eficacia y seguridad de la insulina aspartato bifásica 30/70 en el tratamiento de pacientes con diabetes mellitus tipo 2

Treatment with biphasic insulin aspart 30/70 in patients with DM2 improves glycemic control, irrespective of previous treatment, with a low rate of AE and fewer hypoglycemic episodes in patients previously treated with insulin.